rs45483293
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000196.4(HSD11B2):c.534G>A(p.Glu178Glu) variant causes a synonymous change. The variant allele was found at a frequency of 0.0367 in 1,614,214 control chromosomes in the GnomAD database, including 1,272 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.029 ( 76 hom., cov: 32)
Exomes 𝑓: 0.037 ( 1196 hom. )
Consequence
HSD11B2
NM_000196.4 synonymous
NM_000196.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.44
Publications
29 publications found
Genes affected
HSD11B2 (HGNC:5209): (hydroxysteroid 11-beta dehydrogenase 2) There are at least two isozymes of the corticosteroid 11-beta-dehydrogenase, a microsomal enzyme complex responsible for the interconversion of cortisol and cortisone. The type I isozyme has both 11-beta-dehydrogenase (cortisol to cortisone) and 11-oxoreductase (cortisone to cortisol) activities. The type II isozyme, encoded by this gene, has only 11-beta-dehydrogenase activity. In aldosterone-selective epithelial tissues such as the kidney, the type II isozyme catalyzes the glucocorticoid cortisol to the inactive metabolite cortisone, thus preventing illicit activation of the mineralocorticoid receptor. In tissues that do not express the mineralocorticoid receptor, such as the placenta and testis, it protects cells from the growth-inhibiting and/or pro-apoptotic effects of cortisol, particularly during embryonic development. Mutations in this gene cause the syndrome of apparent mineralocorticoid excess and hypertension. [provided by RefSeq, Feb 2010]
HSD11B2 Gene-Disease associations (from GenCC):
- apparent mineralocorticoid excessInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 16-67436012-G-A is Benign according to our data. Variant chr16-67436012-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 586029.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0868 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HSD11B2 | ENST00000326152.6 | c.534G>A | p.Glu178Glu | synonymous_variant | Exon 3 of 5 | 1 | NM_000196.4 | ENSP00000316786.5 | ||
| HSD11B2 | ENST00000566606.1 | n.*335G>A | non_coding_transcript_exon_variant | Exon 3 of 3 | 5 | ENSP00000473429.1 | ||||
| HSD11B2 | ENST00000567684.2 | n.397G>A | non_coding_transcript_exon_variant | Exon 3 of 4 | 3 | |||||
| HSD11B2 | ENST00000566606.1 | n.*335G>A | 3_prime_UTR_variant | Exon 3 of 3 | 5 | ENSP00000473429.1 |
Frequencies
GnomAD3 genomes AF: 0.0286 AC: 4352AN: 152224Hom.: 76 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
4352
AN:
152224
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0308 AC: 7749AN: 251448 AF XY: 0.0316 show subpopulations
GnomAD2 exomes
AF:
AC:
7749
AN:
251448
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0375 AC: 54814AN: 1461872Hom.: 1196 Cov.: 35 AF XY: 0.0369 AC XY: 26831AN XY: 727240 show subpopulations
GnomAD4 exome
AF:
AC:
54814
AN:
1461872
Hom.:
Cov.:
35
AF XY:
AC XY:
26831
AN XY:
727240
show subpopulations
African (AFR)
AF:
AC:
306
AN:
33480
American (AMR)
AF:
AC:
1041
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
1615
AN:
26136
East Asian (EAS)
AF:
AC:
2
AN:
39700
South Asian (SAS)
AF:
AC:
990
AN:
86258
European-Finnish (FIN)
AF:
AC:
2166
AN:
53410
Middle Eastern (MID)
AF:
AC:
538
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
45739
AN:
1112000
Other (OTH)
AF:
AC:
2417
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
3686
7372
11059
14745
18431
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1704
3408
5112
6816
8520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0285 AC: 4348AN: 152342Hom.: 76 Cov.: 32 AF XY: 0.0274 AC XY: 2043AN XY: 74488 show subpopulations
GnomAD4 genome
AF:
AC:
4348
AN:
152342
Hom.:
Cov.:
32
AF XY:
AC XY:
2043
AN XY:
74488
show subpopulations
African (AFR)
AF:
AC:
362
AN:
41584
American (AMR)
AF:
AC:
444
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
AC:
198
AN:
3470
East Asian (EAS)
AF:
AC:
3
AN:
5176
South Asian (SAS)
AF:
AC:
45
AN:
4828
European-Finnish (FIN)
AF:
AC:
381
AN:
10628
Middle Eastern (MID)
AF:
AC:
39
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2731
AN:
68022
Other (OTH)
AF:
AC:
91
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
221
443
664
886
1107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
25
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 30, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Dec 31, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Apparent mineralocorticoid excess Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.